Matching geography Reports matching your search in: Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|
Pricing: market research reports
Pricing is a challenging area for life science products, be they drug therapies, devices or a new test product. In all industries products are priced to account for market conditions and cost. In healthcare pricing has to be considered in many cases along with reimbursement rates of standard treatments, the economic conditions and healthcare funding in many countries.
Pricing for pharmaceutical products requires a long-term approach. A pricing strategy may be valid given cost and market conditions, but when considers that the earning period of a given therapy may be a decade, this must be accounted for in pricing. Market conditions will also be a factor, in pharmaceuticals, a company must consider the role generics play after patent expiration, generic threats may be present. Some companies have reacted to generic threats with underpricing strategy to reduce the impact of the threat.
Pricing market research reports and industry analysis
US Pharmaceutical Industry – PEST Framework Analysis
11/1/2012 | published by: Aruvian's R'search
... solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. The US continues to generate the ...
|
more...
|
$200.00
|
|
|
$200.00
|
Key Findings: Brazil Pharmaceutical Market Overview
9/27/2012 | published by: Business Insights
... slowing sales growth in more developed markets. Features and benefits Analysis of population demographics, economic wealth, disease burden, level of industrialization, and political structure in Brazil. Insight into the healthcare system, drug regulation, drug pricing, ...
|
more...
|
$1,910.00
|
|
|
$2,995.00
|
|
|
$3,500.00
|
Healthcare, Regulatory and Reimbursement Landscape - Australia
7/24/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape in Australia. It identifies key trends, and most importantly, provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using ...
|
more...
|
$1,995.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
|
|
$1,995.00
|
|
|
$325.00
|
The Pharmaceutical Market in Saudi Arabia
6/22/2012 | published by: Business Insights
... detail. The report also provides profiles of the leading companies, incorporating their product portfolios and growth strategies in Saudi Arabia. Features and benefits Plan your company's strategy for Saudi Arabia by assessing factors driving and ...
|
more...
|
$2,875.00
|
The Pharmaceutical Market in Israel
6/22/2012 | published by: Business Insights
... are also analyzed. Features and benefits Plan your company's strategy for Israel by assessing factors driving and restraining market growth. Forecast the growth of patented and generic markets to 2017. Understand Israel's health insurance and ...
|
more...
|
$2,875.00
|
Emerging Pharmaceutical Markets in the Middle East
6/22/2012 | published by: Business Insights
... An attractiveness index allowing comparison of the five countries along four dimensions is also presented. Features and benefits Forecast pharmaceutical sales for five key Middle East countries to 2017. Gain insights into the relative merits ...
|
more...
|
$4,795.00
|
The Pharmaceutical Market in Egypt
6/22/2012 | published by: Business Insights
... and counterfeits. It examines pharmaceutical sales, manufacturing, trade, and major multinationals and local companies. Features and benefits Understand the key pharmaceutical market characteristics, including total market size, growth drivers and resistors and overall market attractiveness. ...
|
more...
|
$2,875.00
|
Healthcare, Regulatory and Reimbursement Landscape Russia
6/18/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape Vietnam
6/18/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. ...
|
more...
|
$1,995.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
Healthcare, Regulatory and Reimbursement Landscape - Indonesia
5/21/2012 | published by: GlobalData
... and identifies the key trends in Indonesia’s healthcare market. It also provides an insight into the demographic, regulatory, and reimbursement landscape, and the overall healthcare infrastructure. Most importantly, the report provides valuable insights into the ...
|
more...
|
$1,995.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
The Pharmaceutical Market: Poland
5/15/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...
|
more...
|
$1,085.00
|
The Pharmaceutical Market: Japan
5/15/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...
|
more...
|
$1,085.00
|
The Pharmaceutical Market: Germany
5/14/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...
|
more...
|
$1,085.00
|
< prev 1 2 3 4 5 6 7 next >
|